Royalty Pharma PLC (Class A)

12 lis 2026, 20:36 UTC

Shares of Royalty Pharma PLC are declining after the company raised its 2026 guidance, despite a clinical setback for Pelacarsen.

11 lis 2026, 23:16 UTC

Royalty Pharma PLC is trading roughly flat in after-market hours, recovering slightly from an earlier low amid strong monthly performance.

10 lis 2026, 21:07 UTC

Royalty Pharma PLC shares are modestly higher, reaching the upper end of their one-month range as the broader market nears 1% cumulative returns since Monday.

9 lis 2026, 21:03 UTC

Royalty Pharma PLC shares are rising amid high trading volume, having advanced since Friday and trading well above its 20-day moving average.

6 lis 2026, 22:51 UTC

Royalty Pharma PLC shares advanced in after-hours trading, reaching a peak return amid strong performance and significantly above their 20-day moving average.

5 lis 2026, 21:08 UTC

Royalty Pharma PLC traded near unchanged, retracing from a notable high reached earlier in the session, while remaining above its 20-day moving average.

4 lis 2026, 21:04 UTC

Royalty Pharma PLC raised its full-year 2026 guidance for portfolio receipts to $3.50B-$3.55B after reporting strong Q3 results with $890M in receipts.

3 lis 2026, 21:07 UTC

Royalty Pharma PLC shares are declining, pulling back from an earlier gain but remaining above the 20-day moving average and near the upper end of its one-month range.

30 paź 2026, 20:03 UTC

Royalty Pharma PLC shares are advancing, significantly above their 20-day moving average and near the upper end of their one-month range.

29 paź 2026, 20:07 UTC

Royalty Pharma PLC shares are higher, supported by strong momentum in the broader market and gains in key holdings within the XLV ETF during earnings season.

28 paź 2026, 20:07 UTC

Royalty Pharma PLC shares are declining, following a broader market trend lower since Tuesday, despite stabilizing somewhat after an earlier drop.

27 paź 2026, 20:01 UTC

Royalty Pharma PLC is trading modestly higher, supported by a notable increase in market volume and remaining significantly above its 20-day moving average.

26 paź 2026, 22:16 UTC

Royalty Pharma PLC is trading modestly higher in after-market hours, continuing its performance from Monday's close and remaining well above its 20-day moving average.

23 paź 2026, 20:07 UTC

Shares of Royalty Pharma PLC are advancing, showing a slight gain since Thursday's close and recovering to near its highest point during Friday's trading session.

22 paź 2026, 20:02 UTC

Royalty Pharma PLC is gaining amid a broader market downturn, diverging from the recent upward momentum observed in prior sessions.

21 paź 2026, 20:41 UTC

Royalty Pharma PLC is experiencing a notable decline in after-market trading, moving lower since Wednesday's close and trading at the lower end of today's range.

20 paź 2026, 22:46 UTC

Royalty Pharma PLC's shares advanced in after-market hours on Tuesday, remaining just above the previous close and 7.13% above its 20-day moving average.

19 paź 2026, 20:07 UTC

Royalty Pharma PLC shares are declining, hitting a midday low after an early peak.

16 paź 2026, 20:02 UTC

Royalty Pharma PLC declared a quarterly dividend of $0.235 per Class A share, payable on December 10, 2026, to shareholders of record as of November 13, 2026.

15 paź 2026, 20:07 UTC

Royalty Pharma PLC shares advanced, supported by broader market strength, while the Health Care Select Sector SPDR ETF reached a record high.

14 paź 2026, 20:02 UTC

Royalty Pharma PLC is advancing during Wednesday's market hours, continuing its upward trajectory since Tuesday's close with unusually high trading volume.

13 paź 2026, 20:02 UTC

Royalty Pharma PLC shares fell sharply, trading near the low end of their one-month range after an initial rebound earlier in the session.

12 paź 2026, 20:06 UTC

Royalty Pharma PLC is advancing, reflecting a strong performance since Friday's close, with today's price peaking in the early afternoon before settling slightly lower.

9 paź 2026, 21:01 UTC

Royalty Pharma PLC shares traded lower in after-market hours, remaining below their 20-day moving average and near the lower end of their one-month range.

8 paź 2026, 20:13 UTC

Royalty Pharma PLC shares advanced modestly during after-market hours on Thursday, holding steady with no notable fluctuations since the market closed.

7 paź 2026, 19:35 UTC

Royalty Pharma PLC shares advanced modestly after Morgan Stanley raised its price target to $67.00 from $65.00 while maintaining an Overweight rating.

6 paź 2026, 20:12 UTC

Royalty Pharma PLC is trading modestly higher in after-market hours, maintaining a steady position below its 20-day moving average and near the lower end of its one-month range.

5 paź 2026, 20:02 UTC

Royalty Pharma PLC shares fell sharply, continuing a downward trend amid broader pharmaceutical sector weakness and reflecting unusually high market volume.

2 paź 2026, 20:07 UTC

Royalty Pharma PLC shares fell sharply, continuing a downward trend and hitting a session low just before market close, significantly below its 20-day moving average.

1 paź 2026, 20:07 UTC

Royalty Pharma PLC shares fell sharply, remaining below their 20-day moving average and positioned near the lower end of their one-month range.